1 week Pharma Stock Roundup: AZN, BAYRY’s Earnings, ABBV’s Pipeline SetbackZacks
AZN and BAYRY announce Q3 results. ABBV’s studies on schizophrenia candidate, emraclidine, fail to meet goal.
XAZN and BAYRY announce Q3 results. ABBV’s studies on schizophrenia candidate, emraclidine, fail to meet goal.
X